During the past decade, Medical Research Council Laboratories, conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Research Council Laboratories," #1 sponsor was "London School of Hygiene and Tropical Medicine" with 17 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "PATH" with 2 trials sponsored, "St George's, University of London" with 1 trials sponsored and "University of Oxford" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Research Council Laboratories," #1 collaborator was "Department of State for Health and Social Welfare, The Gambia" with 5 trials as a collaborator, "Medical Research Council Unit, The Gambia" with 4 trials as a collaborator, "Medical Research Council" with 3 trials as a collaborator, "University of Oxford" with 3 trials as a collaborator and "National Malaria Control Programme, The Gambia" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Medical Research Council Laboratories," are "Malaria" (10 trials), "Plasmodium Falciparum Malaria" (2 trials), "Anemia" (1 trials), "Covid19" (1 trials) and "Group A Streptococcal Infection" (1 trials). Many other conditions were trialed in "Medical Research Council Laboratories," in a lesser frequency.

Most popular intervention types in "Medical Research Council Laboratories," are "Drug" (11 trials), "Biological" (7 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azithromycin" (2 trials), "AdCH63 ME-TRAP, MVA ME-TRAP" (1 trials), "AdCh63 ME-TRAP, MVA ME-TRAP" (1 trials), "Amodiaquine plus artesunate (AQ/AS)" (1 trials) and "Azithromycin and Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Research Council Laboratories," are 15 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Research Council Laboratories,". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Medical Research Council Laboratories,, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Research Council Laboratories,, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".